Home
Why Opioids
Ensysce
About Us
Breakthrough
The Solution
Our Science
Beyond Opioids
Pipeline
Road Ahead
Our Team - Executive Management
Board of Directors & Advisors
Our Grants
Home
Our Team
Executive Management
Board of Directors
Advisory Board
Investors
More Info
Our Products
Our Pipeline
Our Technology
Press Releases
Partnering
Contact Us
Mobile Nav Toggle
Home
Why Opioids
Ensysce
About Us
Breakthrough
The Solution
Our Science
Beyond Opioids
Pipeline
Road Ahead
Our Team - Executive Management
Board of Directors & Advisors
Our Grants
Home
Our Team
Executive Management
Board of Directors
Advisory Board
Investors
More Info
Our Products
Our Pipeline
Our Technology
Partnering
Contact Us
Financial Results
Investors
Investors
Overview
News
Press Releases
Events & Presentations
IR Calendar
Presentations
Leadership
Management Team
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Filings and Financials
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Investor Resources
Contacts
Email Alerts
FAQs
2022
Q1 2022
Quarter Ended Mar 31, 2022
Earnings Release
PDF
HTML
Audio
Earnings Webcast
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Transcript
PDF
2021
FY 2021
Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF
HTML
Audio
Earnings Webcast
10-K
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Transcript
PDF
Q3 2021
Quarter Ended Sep 30, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q2 2021
Quarter Ended Jun 30, 2021
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Email Alerts
Contacts
RSS News Feed